Search

Search Results

• CAR-T Cell Therapy in Real-World Clinical Practice: An Experience of the NN Alexandrov National Cancer Centre of Belarus

  N.E. Konoplya, Volha Aleksandrovna Kalenik, P.D. Dziameshka, E.Yu. Zharkova, T.V. Savich, T.M. Doroshenko, I.N. Seviaryn, N.M. Bobrova, A.A. Beleevsky, E.Kh. Sarydze, S.L. Polyakov

  305-314

  01.10.2025

• Teclistamab for Multiple Myeloma Therapy: A Literature Review and the First Clinical Use in Russia

  Anastasiya Aleksandrovna Semenova, A.S. Luchinin, A.S. Subbotin, G.S. Tumyan, A.V. Arakelyan, A.I. Cherencova, S.S. Kamyshanov

  388-394

  01.10.2025

• Cardiovascular Toxicity of CAR-T Cell Therapy: A Literature Review

  Shakhabutdin Murtuzalievich Murtuzaliev, E.Yu. Salakheeva, S.A. Kardovskaya, Yu.Yu. Kirichenko, E.A. Siderko, Yu.N. Belenkov, I.S. Ilgisonis

  404-414

  01.10.2024

• Classic and Activating Chimeric Antigen Receptors PD-1 as an Element of Multi-Target Approach to the Treatment of Hematological and Solid Neoplasms

  Kseniya Aleksandrovna Levchuk, A.A. Goldaev, E.A. Stolyarova, P.A. Mateikovich, A.Kh. Valiullina, E.R. Bulatov, A.V. Petukhov, A.A. Daks, N.A. Barlev, E.V. Baidyuk, Ya.G. Toropova

  268-279

  09.06.2023

• CAR-T Therapy of Multiple Myeloma, Based on the Congresses ASH-2021 and ASCO-2022

  Sergei Vyacheslavovich Semochkin

  1-13

  01.01.2023

• Experimental Study of the In Vitro and In Vivo Functional Activity of NKG2D Chimeric Antigen Receptor

  Kseniya Aleksandrovna Levchuk, S.A. Osipova, A.V. Onopchenko, M.L. Vasyutina, E.R. Bulatov, A.Kh. Valiullina, O.N. Demidov, A.V. Petukhov

  327-339

  01.10.2022

• Pharmacoeconomic Analysis of CAR-T Cell Therapy in Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemias

  Irina Vladimirovna Gribkova, A.A. Zavyalov

  205-212

  01.04.2022

• CAR-Т Cells for the Treatment of Chronic Lymphocytic Leukemia: Literature Review

  Irina Vladimirovna Gribkova, A.A. Zav’yalov

  225-230

  01.04.2021

• CAR T-Cell Therapy with NKG2D Chimeric Antigen Receptor in Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome

  Kseniya Aleksandrovna Levchuk, E.V. Belotserkovskaya, D.Yu. Pozdnyakov, L.L. Girshova, A.Yu. Zaritskey, A.V. Petukhov

  138-148

  01.01.2021

• CAR-T Technology and New Opportunities for Tumor Treatment

  Vera Yurevna Pavlova, E.S. Livadnyi

  149-156

  01.01.2021

• Manufacturing of CD19 Specific CAR T-Cells and Evaluation of their Functional Activity in Vitro

  A.V. Petukhov, V.A. Markova, D.V. Motorin, A.K. Titov, N.S. Belozerova, P.M. Gershovich, A.V. Karabel’skii, R.A. Ivanov, E.K. Zaikova, E.Yu. Smirnov, P.A. Butylin, Andrei Yur’evich Zaritskey

  1-9

  01.01.2018

• V(D)J Recombination Excision Circles of B- and T-cells as Prognostic Marker in B-Cell Chronic Lymphocytic Leukemia

  Igor’ Vladimirovich Obraztsov, M.A. Gordukova, N.A. Severina, B.V. Biderman, S.Yu. Smirnova, A.B. Sudarikov, E.A. Nikitin, A.G. Rumyantsev

  131-140

  01.04.2017

• NK-Cell Lymphoblastic Leukemia/Lymphoma (Literature Review and Authors’ Experience)

  M.A. Frenkel’, O.Yu. Baranova, Alina Sergeevna Antipova, N.A. Kupryshina, N.N. Tupitsyn

  208-217

  01.04.2016

• PCR-based clonality detection in angioimmunoblastic T-cell lymphoma

  Yu.V. Sidorova, Ye.Ye. Nikulina, N.G. Chernova, L.G. Gorenkova, Ye.A. Gilyazitdinova, S.K. Kravchenko, A.M. Kovrigina, A.B. Sudarikov

  192-196

  01.04.2014